Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic CancerThomas B. Karasic, Peter J. O’Dwyer, Mark H. O’Hara et al.|JAMA Oncology|2019Cited by 289
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)Dung T. Le, Elizabeth M. Jaffee, Vincent J. Picozzi et al.|Clinical Cancer Research|2019Cited by 260
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsErkut Borazanci, Josep Tabernero, Fei Hua et al.|ESMO Open|2022Cited by 37
Abstract 4706: Evaluating the efficacy of RAS(ON) inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancerTaylor Bargenquast, Sunil Sharma, C. John Wesley et al.|Cancer Research|2025Cited by 1
Preclinical Proof of Concept for a personalized SNAP <sup>TM</sup> -TIL (Specific Neo-Antigen Peptides -TIL) therapy platformTithi Ghosh, Sunil Sharma, Erin Kelley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0